Merus NV (MRUS) insider trading
Every open-market stock purchase and sale by Merus NV executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $7.6B over the last 12 months (4 buys).
- Insiders sold $960K over the last 12 months (2 sales).
- Last insider buy: A/s Genmab (Insider), $7.4B, 9 months ago.
Last 12 months: insiders bought $7.6B (4 buys) and sold $960K (2 sales). Last close $90.00 on Dec 28, 2025.
Recent MRUS insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Dec 29, 2025 | A/s Genmab (Insider) | Bought | $7.4B |
| Dec 29, 2025 | A/s Genmab (Insider) | Bought | $102M |
| Dec 26, 2025 | A/s Genmab (Insider) | Bought | $13.8M |
| Dec 26, 2025 | A/s Genmab (Insider) | Bought | $289K |
| Dec 24, 2025 | A/s Genmab (Insider) | Bought | $9.3M |
| Dec 23, 2025 | A/s Genmab (Insider) | Bought | $54.4M |
| Dec 22, 2025 | A/s Genmab (Insider) | Bought | $1.5M |
| Dec 19, 2025 | A/s Genmab (Insider) | Bought | $6.4M |
| Dec 18, 2025 | A/s Genmab (Insider) | Bought | $20.6M |
| Dec 17, 2025 | A/s Genmab (Insider) | Bought | $14.6M |
| Dec 16, 2025 | A/s Genmab (Insider) | Bought | $11.7M |
| Dec 12, 2025 | Mark T Iwicki (Insider) | Sold (not open market) | $7.1M |
| Dec 12, 2025 | Sven Ante Lundberg (CEO) | Sold (not open market) | $2.9M |
| Dec 12, 2025 | Sven Ante Lundberg (CEO) | Sold (not open market) | $1.6M |
| Dec 12, 2025 | Harry Shuman (VP) | Sold (not open market) | $1.1M |
| Dec 12, 2025 | Sven Ante Lundberg (CEO) | Sold (not open market) | $892K |
| Dec 12, 2025 | Sven Ante Lundberg (CEO) | Sold (not open market) | $892K |
| Dec 12, 2025 | Paolo Pucci (Insider) | Sold (not open market) | — |
| Dec 12, 2025 | Paolo Pucci (Insider) | Sold (not open market) | — |
| Dec 12, 2025 | Paolo Pucci (Insider) | Sold (not open market) | — |
| Dec 12, 2025 | Harry Shuman (VP) | Sold (not open market) | — |
| Dec 12, 2025 | Harry Shuman (VP) | Sold (not open market) | — |
| Dec 12, 2025 | Harry Shuman (VP) | Sold (not open market) | — |
| Dec 12, 2025 | Harry Shuman (VP) | Sold (not open market) | — |
| Dec 12, 2025 | Gregory D Perry (CFO) | Sold (not open market) | — |
Who's trading MRUS
- A/s Genmab, Insider: bought $7.6B (11 buys), last Dec 29, 2025
- Maxine Gowen, Insider: other filings, last Dec 12, 2025
- Jason Haddock, Insider: other filings, last Dec 12, 2025
- Mark T Iwicki, Insider: other filings, last Dec 12, 2025
- Len Kanavy, Insider: other filings, last Dec 12, 2025
- Fabian Zohren, C-suite exec: other filings, last Dec 12, 2025
- Harry Shuman, VP: sold $960K (2 sales), last Dec 12, 2025
- Peter B. Silverman, COO: other filings, last Dec 12, 2025
- Sven Ante Lundberg, CEO: other filings, last Dec 12, 2025
- Anand Mehra, Insider: other filings, last Dec 12, 2025
- Gregory D Perry, CFO: other filings, last Dec 12, 2025
- Paolo Pucci, Insider: other filings, last Dec 12, 2025
- Victor Sandor, Insider: other filings, last Dec 12, 2025
Get free alerts when an insider at Merus NV files a new trade →